Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice
Christian Griñán‐Ferré, Foteini Vasilopoulou, Sònia Abás, et al.
Neurotherapeutics (2018) Vol. 16, Iss. 2, pp. 416-431
Open Access | Times Cited: 24

Showing 24 citing articles:

Astaxanthin attenuates cognitive deficits in Alzheimer’s disease models by reducing oxidative stress via the SIRT1/PGC-1α signaling pathway
Ning Liu, Xiaohong Lyu, Xianglin Zhang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties
Andrea Bagán, Alba López-Ruiz, Sònia Abás, et al.
Journal of Medicinal Chemistry (2025)
Open Access | Times Cited: 1
Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
Yanan Jiao, Jingsheng Zhang, Qiao Wen-jun, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 3294-3309
Open Access | Times Cited: 27
Disease‐modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil
Foteini Vasilopoulou, Sergio Rodríguez‐Arévalo, Andrea Bagán, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 15, pp. 3017-3033
Open Access | Times Cited: 22
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer’s Disease
Sònia Abás, Sergio Rodríguez‐Arévalo, Andrea Bagán, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 7, pp. 3610-3633
Open Access | Times Cited: 20
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
Sergio Rodríguez‐Arévalo, Andrea Bagán, Christian Griñán‐Ferré, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113540-113540
Open Access | Times Cited: 16
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice
Bibiana Castagna Mota, Nathan Ashburner, Laura Abelleira‐Hervas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7320-7320
Open Access | Times Cited: 11
I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway
Foteini Vasilopoulou, Christian Griñán‐Ferré, Sergio Rodríguez‐Arévalo, et al.
GeroScience (2020) Vol. 43, Iss. 2, pp. 965-983
Open Access | Times Cited: 16
Agmatine reverses memory deficits induced by Aβ1–42 peptide in mice: A key role of imidazoline receptors
Nandkishor Kotagale, Madhura Dixit, Harshal Garmelwar, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 196, pp. 172976-172976
Closed Access | Times Cited: 15
Heterocycle-Based Multicomponent Reactions in Drug Discovery: From Hit Finding to Rational Design
Pau Nadal Rodríguez, Ouldouz Ghashghaei, Andrea Bagán, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1488-1488
Open Access | Times Cited: 9
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5
Foteini Vasilopoulou, Andrea Bagán, Sergio Rodríguez‐Arévalo, et al.
Pharmaceutics (2020) Vol. 12, Iss. 5, pp. 475-475
Open Access | Times Cited: 14
Agmatine Protects Against the Progression of Sepsis Through the Imidazoline I2 Receptor-Ribosomal S6 Kinase 2-Nuclear Factor-κB Signaling Pathway
Xuanfei Li, Junyu Zhu, Lixing Tian, et al.
Critical Care Medicine (2019) Vol. 48, Iss. 1, pp. e40-e47
Closed Access | Times Cited: 12
Sex differences in the antidepressant-like response and molecular events induced by the imidazoline-2 receptor agonist CR4056 in rats
Elena Hernández‐Hernández, Sandra Ledesma‐Corvi, Fernando Yáñez, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173527-173527
Open Access | Times Cited: 4
Astrocyte Reactivity in Alzheimer’s Disease: Therapeutic Opportunities to Promote Repair
Nazanin Mirzaei, Nicola Davis, Tsz Wing Chau, et al.
Current Alzheimer Research (2021) Vol. 19, Iss. 1, pp. 1-15
Open Access | Times Cited: 8
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Andrea Bagán, Sergio Rodríguez‐Arévalo, Teresa Taboada, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2381-2381
Open Access | Times Cited: 3
The memory modulatory effect of agmatine in passive avoidance task coincides with alterations of hippocampal CaMKII-α and ERK signaling in mice
Majid Reza Farokhi, Erfan Taherifard, Roksana SoukhakLari, et al.
European Journal of Pharmacology (2022) Vol. 923, pp. 174928-174928
Closed Access | Times Cited: 5
Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I2 Receptor Ligand B06
Andrea Bagán, José Á. Morales-García, Christian Griñán‐Ferré, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5408-5408
Open Access | Times Cited: 4
An Imidazoline 2 Receptor Ligand Relaxes Mouse Aorta via Off-Target Mechanisms Resistant to Aging
Francesc Jiménez‐Altayó, Anna Cabrera, Andrea Bagán, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Disease-modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer’s disease mouse model : A Comparative study with donepezil
Fotini Vasilopoulou, Sergio Rodríguez‐Arévalo, Andrea Bagán, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 5
Evaluating the effects of 2-BFI and tracizoline, two potent I2-imidazoline receptor agonists, on cognitive performance and affect in middle-aged rats
Elena Hernández‐Hernández, M. Julia García‐Fuster
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 5, pp. 989-996
Closed Access | Times Cited: 5
Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats
Gabriela Rusu-Zota, Alexandra Burlui, Elena Rezuş, et al.
Medicina (2021) Vol. 57, Iss. 3, pp. 194-194
Open Access | Times Cited: 4
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Andrea Bagán, Sònia Abás, Judith Palà‐Pujadas, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106935-106935
Open Access | Times Cited: 1
Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model
Foteini Vasilopoulou, Carmen Escolano, Mercé Pallás, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1315-1315
Open Access | Times Cited: 1
(2-Imidazolin-4-yl)phosphonates: Green Chemistry and Biology Walk Together
Andrea Bagán, Sònia Abás, Sergio Rodríguez‐Arévalo, et al.
(2019), pp. 97-97
Open Access
Page 1

Scroll to top